PACS Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeWall Street coverage
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Valuation
- Forward P/E
- 16.00
- PEG ratio
- 1.07
- P/B
- 5.53
- P/S (TTM)
- 1.06
- EV/EBITDA
- 19.93
Profitability & growth
- ROE (TTM)
- 27.1%
- Operating margin
- 8.5%
- Revenue growth YoY
- 11.2%
- Dividend yield
- —
- Beta
- 0.00
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About PACS Group, Inc.
Company profilePACS Group, Inc. is a prominent technology solutions provider dedicated to improving operational efficiency across various industries through its innovative software and hardware systems. The company prioritizes research and development, enabling it to leverage emerging technological trends and lead digital transformation efforts. With a robust portfolio of strategic partnerships and a strong market presence, PACS Group is well-positioned to maintain a competitive edge and deliver sustainable growth, thereby representing an attractive investment opportunity for institutional investors seeking…
Classification
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 90 S. 400 W, SALT LAKE CITY, UT
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
